The Hypothalamus in Alzheimer’s Disease
暂无分享,去创建一个
Stavros J. Baloyannis | I. Baloyannis | I. Mavroudis | Ioannis Mavroudis | Stavros J Baloyannis | Demetrios Mitilineos | Ioannis S Baloyannis | Vassiliki G Costa | V. Costa | Demetrios Mitilineos
[1] S. Bengtsson,et al. Stress steroids as accelerators of Alzheimer's disease. : Effects of chronically elevated levels of allopregnanolone in transgenic AD models. , 2013 .
[2] C. Behl,et al. Protein Homeostasis, Aging and Alzheimer’s Disease , 2012, Molecular Neurobiology.
[3] Hyoung-Gon Lee,et al. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease , 2012, Journal of neurochemistry.
[4] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[5] F. LaFerla,et al. Synaptic Impairment in Alzheimer’s Disease: A Dysregulated Symphony , 2017, Trends in Neurosciences.
[6] Eric J. Nestler,et al. New approaches to antidepressant drug discovery: beyond monoamines , 2006, Nature Reviews Neuroscience.
[7] G. Román,et al. Autonomic dysfunction in neurodegenerative dementias , 2011, Journal of the Neurological Sciences.
[8] Richard J Martin,et al. Assessment of Behavioral and Affective Symptoms in Alzheimer's Disease , 1990, Journal of geriatric psychiatry and neurology.
[9] D. Cai,et al. Hypothalamic microinflammation: a common basis of metabolic syndrome and aging , 2015, Trends in Neurosciences.
[10] J. Auwerx,et al. Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity , 2017, Nature.
[11] A Hofman,et al. Diabetes mellitus and the risk of dementia , 1999, Neurology.
[12] Stavros J. Baloyannis. Mitochondria Are Related to Synaptic Pathology in Alzheimer's Disease , 2011, International journal of Alzheimer's disease.
[13] D. Katare,et al. Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review. , 2016, Diabetes & metabolic syndrome.
[14] C. Hetz,et al. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases , 2014, Nature Reviews Neuroscience.
[15] J. Waterhouse. Circadian rhythms and cognition. , 2010, Progress in brain research.
[16] Jennifer L. Ciuchta,et al. Dendritic spine density, morphology, and fibrillar actin content surrounding amyloid-β plaques in a mouse model of amyloid-β deposition. , 2013, Journal of neuropathology and experimental neurology.
[17] G. Casadesus,et al. Hypothalamic–Pituitary–Gonadal Axis Involvement in Learning and Memory and Alzheimer’s Disease: More than “Just” Estrogen , 2015, Front. Endocrinol..
[18] G. Schellenberg,et al. The genetics and neuropathology of Alzheimer’s disease , 2012, Acta Neuropathologica.
[19] George Perry,et al. Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease , 2017, Oxidative medicine and cellular longevity.
[20] M. West. The precision of estimates in stereological analyses. , 2012, Cold Spring Harbor protocols.
[21] Stavros J. Baloyannis. Alterations of Mitochondria and Golgi Apparatus Are Related to Synaptic Pathology in Alzheimer's Disease , 2013 .
[22] J. Herbert,et al. The Suprachiasmatic Nucleus. The Mind's Clock. , 1994 .
[23] Thomas C. Thannickal. Hypocretin (orexin) pathology in Alzheimer’s disease , 2015 .
[24] D. Maysinger,et al. Letrozole Potentiates Mitochondrial and Dendritic Spine Impairments Induced by β Amyloid , 2013, Journal of aging research.
[25] A. Hernández-Pinto,et al. Somatostatin and Alzheimer's disease , 2008, Molecular and Cellular Endocrinology.
[26] R. Tanzi,et al. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. , 1999, Metal ions in biological systems.
[27] A. Coyne,et al. Negative symptoms in Alzheimer's disease. , 1996, The American journal of psychiatry.
[28] Stavros J. Baloyannis,et al. Mitochondrial alterations in Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[29] M. West. Counting and measuring ultrastructural features of biological samples. , 2013, Cold Spring Harbor protocols.
[30] M. Solas,et al. Interactions Between Age, Stress and Insulin on Cognition: Implications for Alzheimer's Disease , 2010, Neuropsychopharmacology.
[31] Dan Mungas,et al. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. , 2009, Archives of neurology.
[32] Stavros J. Baloyannis. The golgi apparatus in Alzheimer?s disease , 2014 .
[33] B. C. Manning,et al. Sundowning and circadian rhythms in Alzheimer's disease. , 2001, The American journal of psychiatry.
[34] S. Ancoli-Israel,et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women , 2011, Alzheimer's & Dementia.
[35] Yuxiang Sun,et al. Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer's disease mouse model. , 2010, Endocrinology.
[36] P. Deyn,et al. Sleep and Alzheimer's disease : A pivotal role for the suprachiasmatic nucleus , 2017 .
[37] H. Braak,et al. Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.
[38] B. Hyman,et al. Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? , 1993, Trends in Neurosciences.
[39] L. Hasche. Specificity of symptoms of depression in Alzheimer disease: a longitudinal analysis. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[40] Stavros J. Baloyannis,et al. The vascular factor in Alzheimer's disease: A study in Golgi technique and electron microscopy , 2012, Journal of the Neurological Sciences.
[41] T. Maurice,et al. Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model , 2013, Neurobiology of Aging.
[42] W. Rosenblum. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. , 1997, Journal of neuropathology and experimental neurology.
[43] Richard G Stefanacci,et al. The costs of Alzheimer's disease and the value of effective therapies. , 2011, The American journal of managed care.
[44] A. Alzheimer. Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .
[45] M. Roth,et al. The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.
[46] W. Balch,et al. Membrane Dynamics at the Endoplasmic Reticulum–Golgi Interface , 1997, The Journal of cell biology.
[47] Ashok Balasubramanyam,et al. The Role of the Immune System in Obesity and Insulin Resistance , 2013, Journal of obesity.
[48] W. Thies,et al. 2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.
[49] H. Braak,et al. Neurofibrillary pathology in the human paraventricular and supraoptic nuclei , 1997, Acta Neuropathologica.
[50] Sholl Da. Dendritic organization in the neurons of the visual and motor cortices of the cat. , 1953 .
[51] D. German,et al. Hypothalamic pathology in Alzheimer's disease , 1987, Neuroscience Letters.
[52] Wei Jia,et al. Hyperinsulinemia, insulin resistance and cognitive decline in older cohort. , 2012, Biomedical and environmental sciences : BES.
[53] Stavros J. Baloyannis. Golgi apparatus and protein trafficking in Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.
[54] H. Gundersen,et al. Direct and efficient stereological estimation of total cell quantities using electron microscopy , 2006, Journal of microscopy.
[55] D. Swaab,et al. The human pineal gland and melatonin in aging and Alzheimer's disease , 2005, Journal of pineal research.
[56] Q. Tian,et al. Melatonin in Alzheimer’s Disease , 2013, International journal of molecular sciences.
[57] E. Peskind,et al. Hypothalamic pituitary adrenocortical and sympathetic nervous system responses to the cold pressor test in Alzheimer’s disease , 2000, Biological Psychiatry.
[58] E. Sibille,et al. Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target? , 2013, Front. Pharmacol..
[59] D. Marks,et al. Hypothalamic mechanisms in cachexia , 2010, Physiology & Behavior.
[60] Stavros J. Baloyannis. The Hypothalamus in Alzheimer’s Disease , 2015 .
[61] W. M. van der Flier,et al. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[62] Olivier Piguet,et al. Eating and hypothalamus changes in behavioral-variant frontotemporal dementia , 2011, Annals of neurology.
[63] Philip Scheltens,et al. Circadian rest—activity rhythm disturbances in alzheimer's disease , 1996, Biological Psychiatry.
[64] Eric D Vidoni,et al. Is Alzheimer's disease a systemic disease? , 2014, Biochimica et biophysica acta.
[65] J. Quinn,et al. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.
[66] D. Praticò,et al. Stress and HPA Axis Dysfunction in Alzheimer’s Disease , 2013 .
[67] Stavros J. Baloyannis,et al. Dendritic and spinal pathology in the acoustic cortex in Alzheimer's disease: morphological and morphometric estimation by Golgi technique and electron microscopy , 2007, Acta oto-laryngologica.
[68] M. West. Estimating volume in biological structures. , 2012, Cold Spring Harbor protocols.
[69] P. Reddy,et al. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[70] David Loewenstein,et al. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. , 2006, Archives of general psychiatry.
[71] C. Saper,et al. From Lesions to Leptin Hypothalamic Control of Food Intake and Body Weight , 1999, Neuron.
[72] Seung-Chul Hong,et al. Sleep and Alzheimer’s Disease , 2015 .
[73] S. Budd,et al. Mitochondria in the life and death of neurons. , 1998, Essays in biochemistry.
[74] C. You,et al. The circadian rhythm of arterial blood pressure in Alzheimer disease (AD) patients without hypertension , 2013, Blood pressure.
[75] G. Knudsen,et al. Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade? , 2011, Journal of Alzheimer's disease : JAD.
[76] J R Hodges,et al. Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer’s disease , 2002, Journal of neurology, neurosurgery, and psychiatry.
[77] Estimating surface area in biological structures. , 2013, Cold Spring Harbor protocols.
[78] N. Mercuri,et al. Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease , 2017, Journal of Neurology.
[79] E. Stopa,et al. Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease , 1995, Neurobiology of Aging.
[80] Stavros J. Baloyannis. Dendritic pathology in Alzheimer's disease , 2009, Journal of the Neurological Sciences.
[81] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[82] R. Mayeux,et al. Review - Part of the Special Issue: Alzheimer's Disease - Amyloid, Tau and Beyond Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers , 2014 .
[83] Stavros J. Baloyannis. Recent progress of the Golgi technique and electron microscopy to examine dendritic pathology in Alzheimer’s disease , 2013 .
[84] U. Schibler,et al. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. , 2010, Annual review of physiology.
[85] M. Beal,et al. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. , 2008, Trends in molecular medicine.
[86] M. Beal,et al. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.
[87] S. Lacalle,et al. Cell loss in supraoptic and paraventricular nucleus in Alzheimer's disease , 1993, Brain Research.
[88] J. Xia,et al. Alzheimer's Disease Risk Genes and Lipid Regulators. , 2016, Journal of Alzheimer's disease : JAD.
[89] M. Abercrombie. Estimation of nuclear population from microtome sections , 1946, The Anatomical record.
[90] M. Haan. Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease , 2006, Nature Clinical Practice Neurology.
[91] Stavros J. Baloyannis. Oxidative stress and mitochondria alterations in Alzheimer's disease , 2000, Neurobiology of Aging.
[92] B. Jacobs,et al. Life‐span dendritic and spine changes in areas 10 and 18 of human cortex: A quantitative golgi study , 1997, The Journal of comparative neurology.
[93] Berislav V. Zlokovic,et al. Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.
[94] S. M. Sumi,et al. Subcortical degeneration in Alzheimer's disease , 1985, Neurology.
[95] D. C. Sterio. The unbiased estimation of number and sizes of arbitrary particles using the disector , 1984, Journal of microscopy.
[96] J. Fiala,et al. Cylindrical diameters method for calibrating section thickness in serial electron microscopy , 2001, Journal of microscopy.
[97] H. J. G. Gundersen,et al. Unbiased stereological estimation of the total number of synapses in a brain region , 1996, Journal of neurocytology.
[98] Virginia M. Y. Lee,et al. Molecular features of hypothalamic plaques in Alzheimer's disease. , 1991, The American journal of pathology.
[99] H J Gundersen,et al. The efficiency of systematic sampling in stereology and its prediction * , 1987, Journal of microscopy.
[100] R. Hales,et al. J Neuropsychiatry Clin Neurosci , 1992 .
[101] D. Butterfield,et al. Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment , 2009, Journal of bioenergetics and biomembranes.
[102] A. Feuerverger,et al. Statistical methods for assessing the dimensions of synaptic vesicles in nerve terminals , 2000, Journal of Neuroscience Methods.
[103] Stavros J. Baloyannis. Staining neurons with Golgi techniques in degenerative diseases of the brain , 2015, Neural regeneration research.
[104] W. Brooks,et al. Reduced limbic and hypothalamic volumes correlate with bone density in early Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[105] M. Beal,et al. Mitochondrial Dysfunction in Neurodegenerative Diseases , 2012, Journal of Pharmacology and Experimental Therapeutics.
[106] Josep Garre-Olmo,et al. Severity of dementia, anosognosia, and depression in relation to the quality of life of patients with Alzheimer disease: discrepancies between patients and caregivers. , 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[107] S. Gauthier,et al. Depression in Alzheimer's Disease: Receiver Operating Characteristic Analysis of the Cornell Scale for Depression in Dementia and the Hamilton Depression Scale , 1994, Journal of geriatric psychiatry and neurology.
[108] Stuart Maudsley,et al. Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. , 2012, Current Alzheimer research.
[109] The cardinal features of cognitive and noncognitive dysfunction and the differential efficacy of tacrine in Alzheimer's disease patients. , 1996, Journal of biopharmaceutical statistics.
[110] D. Bennett,et al. Proneness to psychological distress and risk of Alzheimer disease in a biracial community , 2005, Neurology.
[111] K. Jellinger,et al. Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.
[112] Stavros J. Baloyannis. Staining of dead neurons by the Golgi method in autopsy material. , 2015, Methods in molecular biology.
[113] R. Kalaria,et al. Plasma and platelet clusterin ratio is altered in Alzheimer's disease patients with distinct neuropsychiatric symptoms: findings from a pilot study , 2015, International journal of geriatric psychiatry.
[114] Bernhard T. Baune,et al. The Circadian System in Alzheimer’s Disease: Disturbances, Mechanisms, and Opportunities , 2013, Biological Psychiatry.
[115] Filippo Caraci,et al. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. , 2010, European journal of pharmacology.
[116] T. Hökfelt,et al. Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer’s disease , 2015, Acta Neuropathologica.
[117] Alzheimer’s Association. 2010 Alzheimer's disease facts and figures , 2010, Alzheimer's & Dementia.
[118] P. Reddy,et al. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. , 2012, Human molecular genetics.
[119] S. Ortolano,et al. New Insights in the Amyloid-Beta Interaction with Mitochondria , 2012, Journal of aging research.
[120] Stavros J. Baloyannis,et al. Dendritic and spinal pathology in the acoustic cortex in Alzheimer's disease: Morphological estimation in Golgi technique and electron microscopy , 2011, Acta oto-laryngologica.
[121] D F Swaab,et al. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. , 1999, The Journal of clinical endocrinology and metabolism.
[122] J. Geddes,et al. Synaptic Mitochondria Are More Susceptible to Ca2+Overload than Nonsynaptic Mitochondria* , 2006, Journal of Biological Chemistry.
[123] R. Mrak,et al. Microglia and neuroinflammation: a pathological perspective , 2004 .
[124] K. Blennow,et al. Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease , 2015, Neuroscience Letters.
[125] E. Fliers,et al. The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease , 1990, Neurobiology of Aging.
[126] B. Ott,et al. Apathy and loss of insight in Alzheimer's disease: a SPECT imaging study. , 1996, The Journal of neuropsychiatry and clinical neurosciences.
[127] Claire S. Adjiman,et al. Efficient Screening and Selection of Post-combustion CO2 Capture Solvents , 2014 .
[128] M. Storandt,et al. Temporal memory for remote events in healthy aging and dementia. , 1998, Psychology and aging.
[129] M. Wikström,et al. Age-related changes in electrophysiological properties of the mouse suprachiasmatic nucleus in vitro , 2005, Brain Research Bulletin.
[130] B. Kolb,et al. The Cerebral cortex of the rat , 1990 .
[131] John E. Johnson. Current trends in morphological techniques , 1981 .